Financial Snapshot

Revenue
$11.20M
TTM
Gross Margin
62.12%
TTM
Net Earnings
-$15.18M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
114.87%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$1.072M
Q3 2024
Cash
Q3 2024
P/E
-0.1834
Nov 29, 2024 EST
Free Cash Flow
-$4.527M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue $14.73M $14.40M $8.421M $9.934M $6.599M $12.51M $18.23M $11.90M $4.381M $1.054M $3.480M $6.950M $11.02M $9.750M $15.68M $6.720M $5.910M $1.530M $0.00
YoY Change 2.24% 71.05% -15.23% 50.54% -47.24% -31.39% 53.23% 171.56% 315.65% -69.71% -49.93% -36.93% 13.03% -37.82% 133.33% 13.71% 286.27%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue $14.73M $14.40M $8.421M $9.934M $6.599M $12.51M $18.23M $11.90M $4.381M $1.054M $3.480M $6.950M $11.02M $9.750M $15.68M $6.720M $5.910M $1.530M $0.00
Cost Of Revenue $6.831M $6.623M $2.776M $3.970M $1.738M $1.503M $2.784M $2.464M $1.261M $486.0K $160.0K $9.280M
Gross Profit $7.895M $7.781M $5.645M $5.964M $4.861M $11.01M $15.45M $9.433M $3.120M $568.0K $3.320M -$2.330M
Gross Profit Margin 53.61% 54.02% 67.03% 60.04% 73.66% 87.98% 84.73% 79.29% 71.22% 53.89% 95.4% -33.53%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Selling, General & Admin $12.83M $15.29M $14.46M $12.11M $14.08M $18.62M $22.35M $19.04M $18.53M $7.989M $6.340M $5.980M $10.86M $11.11M $5.610M $5.640M $4.370M $2.970M $1.620M
YoY Change -16.07% 5.7% 19.48% -14.01% -24.39% -16.69% 17.34% 2.78% 131.93% 26.01% 6.02% -44.94% -2.25% 98.04% -0.53% 29.06% 47.14% 83.33% 20.0%
% of Gross Profit 162.51% 196.47% 256.21% 202.97% 289.59% 169.17% 144.68% 201.89% 593.88% 1406.51% 190.96%
Research & Development $68.00K $174.0K $44.00K $285.0K $184.0K $259.0K $410.0K $1.371M $5.728M $9.483M $12.46M $9.910M $8.620M $7.340M $9.600M $7.420M $4.090M $1.950M
YoY Change -60.92% 295.45% -84.56% 54.89% -28.96% -36.83% -70.09% -76.06% -39.6% -23.89% 14.97% 17.44% -23.54% 29.38% 81.42% 109.74% 31.76%
% of Gross Profit 0.86% 2.24% 0.78% 4.78% 3.79% 2.35% 2.65% 14.53% 183.59% 1669.54% 375.3%
Depreciation & Amortization $203.0K $120.0K $119.0K $51.00K $65.00K $266.0K $95.00K $114.0K $164.0K $232.0K $310.0K $340.0K $430.0K $430.0K $370.0K $300.0K $180.0K $70.00K $50.00K
YoY Change 69.17% 0.84% 133.33% -21.54% -75.56% 180.0% -16.67% -30.49% -29.31% -25.16% -8.82% -20.93% 0.0% 16.22% 23.33% 66.67% 157.14% 40.0% 25.0%
% of Gross Profit 2.57% 1.54% 2.11% 0.86% 1.34% 2.42% 0.62% 1.21% 5.26% 40.85% 9.34%
Operating Expenses $12.90M $22.20M $14.51M $12.39M $14.26M $18.88M $22.76M $20.42M $24.26M $17.47M $18.80M $5.980M $20.77M $19.72M $12.94M $15.23M $11.79M $7.060M $3.570M
YoY Change -41.9% 53.02% 17.09% -13.12% -24.45% -17.05% 11.47% -15.84% 38.83% -7.06% 214.38% -71.21% 5.32% 52.4% -15.04% 29.18% 67.0% 97.76% 26.15%
Operating Profit -$5.003M -$14.42M -$8.862M -$6.426M -$9.400M -$7.871M -$7.311M -$10.98M -$21.14M -$16.90M -$15.48M -$8.310M
YoY Change -65.3% 62.68% 37.91% -31.64% 19.43% 7.66% -33.43% -48.04% 25.04% 9.2% 86.28%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Interest Expense $20.00K $4.085M $4.615M -$5.213M $120.0K $1.311M -$101.0K -$2.099M $2.149M $1.664M -$560.0K $1.440M -$730.0K $0.00 $0.00
YoY Change -99.51% -11.48% -188.53% -4444.17% -90.85% -1398.02% -95.19% -197.67% 29.15% -397.14% -138.89% -297.26%
% of Operating Profit
Other Income/Expense, Net -$2.064M -$276.0K -$1.577M $605.0K -$1.425M $19.00K $12.00K -$68.00K $17.00K $48.00K $0.00 -$160.0K -$30.00K $260.0K -$40.00K $400.0K $490.0K $240.0K $110.0K
YoY Change 647.83% -82.5% -360.66% -142.46% -7600.0% 58.33% -117.65% -500.0% -64.58% -100.0% 433.33% -111.54% -750.0% -110.0% -18.37% 104.17% 118.18% 450.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Pretax Income -$9.640M -$10.61M -$5.824M -$11.03M -$9.652M -$6.541M -$7.400M -$13.15M -$18.97M -$15.19M -$16.04M -$7.030M -$10.51M -$9.710M $2.700M -$8.110M -$5.390M -$5.290M -$3.460M
YoY Change -9.13% 82.14% -47.22% 14.32% 47.56% -11.61% -43.72% -30.69% 24.87% -5.29% 128.17% -33.11% 8.24% -459.63% -133.29% 50.46% 1.89% 52.89% 23.57%
Income Tax $0.00 $0.00 $5.000K $6.000K $4.000K $3.000K $2.000K $2.000K $2.000K $0.00 $0.00 $0.00 $50.00K $10.00K $0.00 $10.00K $0.00 $0.00
% Of Pretax Income 0.37%
Net Earnings -$16.70M -$10.61M -$5.824M -$11.04M -$9.658M -$6.545M -$7.403M -$13.15M -$18.97M -$15.19M -$16.04M -$7.030M -$10.51M -$9.760M $2.700M -$8.110M -$5.400M -$5.290M -$3.460M
YoY Change 57.4% 82.14% -47.24% 14.3% 47.56% -11.59% -43.71% -30.69% 24.87% -5.27% 128.17% -33.11% 7.68% -461.48% -133.29% 50.19% 2.08% 52.89% 23.57%
Net Earnings / Revenue -113.38% -73.65% -69.16% -111.12% -146.36% -52.33% -40.61% -110.54% -433.07% -1441.56% -460.92% -101.15% -95.37% -100.1% 17.22% -120.68% -91.37% -345.75%
Basic Earnings Per Share -$3.96 -$10.10 -$0.15 -$0.31 -$0.48 -$0.39 -$0.48 -$1.40 -$6.82 -$7.65
Diluted Earnings Per Share -$3.96 -$10.10 -$133.4K -$0.31 -$0.48 -$0.46 -$0.48 -$1.40 -$6.82 -$7.65 -$10.48M -$5.958M -$10.20M -$10.49M $2.935M -$9.541M -$15.00M -$23.00M -$18.21M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Cash & Short-Term Investments $3.130M $5.362M $7.504M $11.95M $6.937M $3.183M $3.199M $9.512M $2.385M $5.429M $13.05M $16.87M $14.14M $12.81M $11.29M $12.10M $22.35M $11.09M $3.210M
YoY Change -41.63% -28.54% -37.22% 72.29% 117.94% -0.5% -66.37% 298.83% -56.07% -58.4% -22.64% 19.31% 10.38% 13.46% -6.69% -45.86% 101.53% 245.48%
Cash & Equivalents $3.130M $5.362M $7.504M $11.95M $6.937M $3.183M $3.199M $9.512M $2.385M $5.429M $10.50M $12.74M $8.430M $11.53M $10.99M $12.10M $10.94M $4.900M $2.210M
Short-Term Investments $2.550M $4.140M $5.710M $1.270M $300.0K $0.00 $11.41M $6.180M $1.000M
Other Short-Term Assets $388.0K $560.0K $778.0K $576.0K $886.0K $1.760M $1.663M $1.966M $261.0K $729.0K $720.0K $450.0K $420.0K $450.0K $510.0K $410.0K $420.0K $230.0K $80.00K
YoY Change -30.71% -28.02% 35.07% -34.99% -49.66% 5.83% -15.41% 653.26% -64.2% 1.25% 60.0% 7.14% -6.67% -11.76% 24.39% -2.38% 82.61% 187.5%
Inventory $2.877M $3.437M $3.220M $608.0K $492.0K $280.0K $504.0K $873.0K $1.345M $521.0K $230.0K $20.00K
Prepaid Expenses
Receivables $759.0K $1.973M $1.668M $1.106M $1.066M $3.385M $3.629M $2.120M $536.0K $273.0K $780.0K $940.0K $0.00 $500.0K $3.800M $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $7.154M $11.33M $13.17M $14.24M $9.381M $8.608M $8.995M $14.47M $4.527M $6.952M $14.79M $18.28M $14.56M $13.75M $15.61M $12.51M $22.77M $11.31M $3.300M
YoY Change -36.87% -13.96% -7.53% 51.82% 8.98% -4.3% -37.84% 219.66% -34.88% -53.0% -19.09% 25.55% 5.89% -11.92% 24.78% -45.06% 101.33% 242.73%
Property, Plant & Equipment $1.383M $1.950M $604.0K $520.0K $1.362M $201.0K $471.0K $371.0K $395.0K $436.0K $720.0K $890.0K $1.270M $1.590M $1.810M $1.460M $1.150M $550.0K $270.0K
YoY Change -29.08% 222.85% 16.15% -61.82% 577.61% -57.32% 26.95% -6.08% -9.4% -39.44% -19.1% -29.92% -20.13% -12.15% 23.97% 26.96% 109.09% 103.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $497.0K $489.0K $476.0K $476.0K $477.0K $552.0K $613.0K $539.0K $155.0K $149.0K $140.0K $60.00K $140.0K $170.0K $110.0K $0.00
YoY Change 1.64% 2.73% 0.0% -0.21% -13.59% -9.95% 13.73% 247.74% 4.03% 6.43% 133.33% -57.14% -17.65% 54.55%
Total Long-Term Assets $1.880M $5.067M $10.81M $996.0K $1.839M $753.0K $1.084M $910.0K $550.0K $585.0K $860.0K $960.0K $1.400M $1.770M $1.910M $1.460M $1.150M $560.0K $260.0K
YoY Change -62.9% -53.12% 985.14% -45.84% 144.22% -30.54% 19.12% 65.45% -5.98% -31.98% -10.42% -31.43% -20.9% -7.33% 30.82% 26.96% 105.36% 115.38%
Total Assets $9.034M $16.40M $23.98M $15.24M $11.22M $9.361M $10.08M $15.38M $5.077M $7.537M $15.65M $19.24M $15.96M $15.52M $17.52M $13.97M $23.92M $11.87M $3.560M
YoY Change
Accounts Payable $1.130M $1.080M $1.045M $302.0K $331.0K $551.0K $466.0K $455.0K $2.483M $1.865M $1.670M $460.0K $470.0K $410.0K $270.0K $410.0K $140.0K $370.0K $140.0K
YoY Change 4.63% 3.35% 246.03% -8.76% -39.93% 18.24% 2.42% -81.68% 33.14% 11.68% 263.04% -2.13% 14.63% 51.85% -34.15% 192.86% -62.16% 164.29%
Accrued Expenses $1.065M $1.370M $1.003M $1.801M $2.708M $973.0K $1.672M $1.801M $1.980M $1.055M $1.620M $1.340M $1.060M $730.0K $1.230M $1.170M $1.140M $520.0K $170.0K
YoY Change -22.26% 36.59% -44.31% -33.49% 178.31% -41.81% -7.16% -9.04% 87.68% -34.88% 20.9% 26.42% 45.21% -40.65% 5.13% 2.63% 119.23% 205.88%
Deferred Revenue
YoY Change
Short-Term Debt $1.137M $0.00 $105.0K $0.00 $2.611M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $0.00 $110.0K $370.0K $410.0K $260.0K $0.00
YoY Change -100.0% -70.27% -9.76% 57.69%
Total Short-Term Liabilities $4.278M $4.257M $3.442M $2.833M $5.687M $3.847M $4.979M $4.323M $4.633M $3.345M $3.630M $3.170M $2.840M $2.720M $4.040M $4.480M $4.580M $3.390M $310.0K
YoY Change 0.49% 23.68% 21.5% -50.18% 47.83% -22.74% 15.17% -6.69% 38.51% -7.85% 14.51% 11.62% 4.41% -32.67% -9.82% -2.18% 35.1% 993.55%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.655M $0.00 $0.00 $0.00 $0.00 $0.00 $110.0K $480.0K $550.0K $0.00 $0.00
YoY Change -100.0% -100.0% -77.08% -12.73%
Other Long-Term Liabilities $1.442M $1.588M $10.37M $87.00K $4.560M $560.0K $2.506M $3.957M $3.887M $2.344M $3.510M $2.010M $3.780M $2.300M $0.00 $1.670M $4.480M $6.670M $0.00
YoY Change -9.19% -84.68% 11813.79% -98.09% 714.29% -77.65% -36.67% 1.8% 65.83% -33.22% 74.63% -46.83% 64.35% -100.0% -62.72% -32.83%
Total Long-Term Liabilities $1.442M $1.588M $10.37M $87.00K $4.560M $560.0K $2.506M $3.957M $5.542M $2.344M $3.510M $2.010M $3.780M $2.300M $110.0K $2.150M $5.030M $6.670M $0.00
YoY Change -9.19% -84.68% 11813.79% -98.09% 714.29% -77.65% -36.67% -28.6% 136.43% -33.22% 74.63% -46.83% 64.35% 1990.91% -94.88% -57.26% -24.59%
Total Liabilities $5.720M $5.845M $13.81M $2.920M $10.25M $4.407M $7.485M $8.280M $10.18M $5.689M $7.130M $5.190M $6.620M $5.030M $4.180M $6.620M $9.600M $10.05M $310.0K
YoY Change -2.14% -57.67% 372.84% -71.5% 132.52% -41.12% -9.6% -18.62% 78.85% -20.21% 37.38% -21.6% 31.61% 20.33% -36.86% -31.04% -4.48% 3141.94%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Basic Shares Outstanding 4.215M 1.610M 43.66M 35.08M 21.64M 16.92M 15.32M 9.408M 2.784M 1.985M
Diluted Shares Outstanding 35.08M 21.64M 17.06M 15.32M 9.408M 2.784M 1.985M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.7844 Million

About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Emeryville, California and currently employs 24 full-time employees. The company went IPO on 2007-10-26. NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. The company offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. The company also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.

Industry: Pharmaceutical Preparations Peers: AVENUE THERAPEUTICS, INC. Dermata Therapeutics, Inc. Evoke Pharma Inc KIORA PHARMACEUTICALS INC Grapefruit USA, Inc JOHNSON & JOHNSON One World Products, Inc. Sonoma Pharmaceuticals, Inc. SenesTech, Inc. Stem Holdings, Inc.